U.S. markets close in 26 minutes

Scopus BioPharma Inc. (SCPS)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
4.2300-0.1300 (-2.98%)
As of 3:33PM EDT. Market open.
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Yahoo Finance Plus required to access monthly data
Subscribe to Yahoo Finance Plus Essential to download historical data
As of Date: 9/20/2021
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 7

Trading Information

Stock Price History

Beta (5Y Monthly) N/A
52-Week Change 3-26.35%
S&P500 52-Week Change 334.88%
52 Week High 347.8600
52 Week Low 34.0000
50-Day Moving Average 34.9643
200-Day Moving Average 36.6050

Share Statistics

Avg Vol (3 month) 3449.09k
Avg Vol (10 day) 3195.89k
Shares Outstanding 518.09M
Implied Shares Outstanding 6N/A
Float 8.31M
% Held by Insiders 159.23%
% Held by Institutions 10.84%
Shares Short (Aug 30, 2021) 476k
Short Ratio (Aug 30, 2021) 40.15
Short % of Float (Aug 30, 2021) 40.73%
Short % of Shares Outstanding (Aug 30, 2021) 40.42%
Shares Short (prior month Jul 29, 2021) 425.8k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2020
Most Recent Quarter (mrq)Jun 29, 2021


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-299.80%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -19.95M
Net Income Avi to Common (ttm)-21.25M
Diluted EPS (ttm)-1.4250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)6.26M
Total Cash Per Share (mrq)0.35
Total Debt (mrq)2.8M
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.77
Book Value Per Share (mrq)-0.11

Cash Flow Statement

Operating Cash Flow (ttm)-6.34M
Levered Free Cash Flow (ttm)-7.11M